Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219108 · ClinicalTrials.gov registry record · NA
Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
A NA study of Acute Medical Conditions and Acute Neurological Injury, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07219108: Recruiting NA study of Acute Medical Conditions and Acute Neurological Injury, sponsored by Washington University School of Medicine.
NCT07219108 is a NA study of Acute Medical Conditions and Acute Neurological Injury that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219108, a NA study of Acute Medical Conditions and Acute Neurological Injury, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.
Primary Outcome
Quantification of patients who need tracheostomy due to prolonged intubation.
Conditions Studied
Interventions
- DEVICE Auricular Vagus Nerve Stimulation
- DEVICE Sham Auricular Vagus nerve Stimulation
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-09-24 |
| Est. Completion | 2027-09-23 |
| Phase | NA |
What NCT07219108 shows while recruiting
NCT07219108 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Acute Medical Conditions appearing as the primary indexed condition, and to 2 interventions - of which Auricular Vagus Nerve Stimulation is the first listed.
NCT07219108 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07219108 about?
NCT07219108 is a clinical study titled "Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU". This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.
What is the current status of trial NCT07219108?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-09-24. Estimated completion is 2027-09-23.
What conditions does trial NCT07219108 study?
This clinical trial studies the following conditions: Acute Medical Conditions, Acute Neurological Injury.
What interventions are being tested in trial NCT07219108?
The interventions under investigation include: Auricular Vagus Nerve Stimulation (DEVICE), Sham Auricular Vagus nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT07219108?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219108 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Medical Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219108's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI